VTv Dividends Paid from 2010 to 2024

VTVT Stock  USD 16.70  0.86  4.90%   
VTv Therapeutics Dividends Paid yearly trend continues to be comparatively stable with very little volatility. Dividends Paid is likely to outpace its year average in 2024. Dividends Paid is the total amount of dividends that vTv Therapeutics has paid out to its shareholders over a specific period. View All Fundamentals
 
Dividends Paid  
First Reported
2010-12-31
Previous Quarter
1.1 M
Current Value
1.2 M
Quarterly Volatility
541.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
  
Check out the analysis of VTv Therapeutics Correlation against competitors.
For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.

Latest VTv Therapeutics' Dividends Paid Growth Pattern

Below is the plot of the Dividends Paid of vTv Therapeutics over the last few years. It is the total amount of dividends that a company has paid out to its shareholders over a specific period. VTv Therapeutics' Dividends Paid historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Dividends Paid10 Years Trend
Slightly volatile
   Dividends Paid   
       Timeline  

VTv Dividends Paid Regression Statistics

Arithmetic Mean486,576
Geometric Mean0.00
Coefficient Of Variation111.29
Mean Deviation519,014
Median0.00
Standard Deviation541,507
Sample Variance293.2B
Range1.2M
R-Value0.89
Mean Square Error66.7B
R-Squared0.79
Slope107,535
Total Sum of Squares4.1T

VTv Dividends Paid History

20241.2 M
20231.1 M
2018992 K

About VTv Therapeutics Financial Statements

VTv Therapeutics shareholders use historical fundamental indicators, such as Dividends Paid, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Dividends Paid1.1 M1.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for VTv Stock Analysis

When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.